Meng, Huan <br/><br/>
Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo.  [electronic resource] 

 -  ACS nano  Feb 2013 
 - 994-1005 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1936-086X 
<br/><br/><label>Standard No.: </label>10.1021/nn3044066  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Breast Neoplasms--drug therapy<br/>Cardiovascular System--drug effects<br/>Cell Transformation, Neoplastic<br/>Doxorubicin--adverse effects<br/>Drug Carriers--chemistry<br/>Drug Resistance, Multiple--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Humans<br/>MCF-7 Cells<br/>Mice<br/>Nanoparticles--chemistry<br/>Porosity<br/>RNA, Small Interfering--genetics<br/>Silicon Dioxide--chemistry